Key result
Uncorrected CHD links to elevated serum activin A, with further increases in CHD-PAH.
Why the study?
PAH due to congenital heart disease is a major problem in developing countries, and activin A may have a role in PAH development and progression among uncorrected CHD.
Are serum activin A levels increased in patients with congenital heart disease-associated pulmonary artery hypertension compared to controls?
Observational
Are serum activin A levels increased in patients with congenital heart disease-associated pulmonary artery hypertension compared to controls?
Serum activin A levels are elevated in uncorrected congenital heart disease and further increased in those with associated pulmonary arterial hypertension, suggesting its potential as a biomarker for PAH development.
Answers are grounded in this paper and cite their sources.
Elevated activin A may support biomarker exploration in CHD-PAH; hypothesis-generating and requires prospective validation before any clinical role.
Activin A, a member of TGF-β superfamily, has been implicated in the pathogenesis of pulmonary artery hypertension (PAH). PAH due to congenital heart disease (CHD-PAH) is a major problem in developing countries. Activin A may have a role in PAH development and progression among uncorrected CHD. In this comparative study, serum activin A level was significantly increased in subjects with uncorrected CHD without the presence of PH and were more significantly risen in CHD-PAH, as compared to control. The utilization of serum activin A measurement seems promising to identify uncorrected CHD patients with PAH development and progression.
No takes yet. Share an insight, caveat, or question.
Hadwiono et al. (2023) conducted an observational in Congenital heart disease-associated pulmonary artery hypertension (CHD-PAH). Serum activin A vs. Control was evaluated on Serum activin A level. Serum activin A levels were significantly increased in uncorrected congenital heart disease patients without pulmonary hypertension, and further elevated in CHD-PAH compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: